Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2012 1
2013 2
2014 4
2017 1
2019 4
2020 5
2021 3
2022 2
2023 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Immunovirotherapy for glioblastoma.
Ning J, Wakimoto H, Rabkin SD. Ning J, et al. Cell Cycle. 2014;13(2):175-6. doi: 10.4161/cc.27039. Epub 2013 Nov 14. Cell Cycle. 2014. PMID: 24241205 Free PMC article. No abstract available.
Editorial: Recent advances in oncolytic virus therapy for brain tumors.
Askari FS, Mohebbi A, Ning J, Kurozumi K, Wakimoto H. Askari FS, et al. Among authors: ning j. Front Cell Infect Microbiol. 2023 Aug 17;13:1271559. doi: 10.3389/fcimb.2023.1271559. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37662010 Free PMC article. No abstract available.
Functional virus-specific memory T cells survey glioblastoma.
Ning J, Gavil NV, Wu S, Wijeyesinghe S, Weyu E, Ma J, Li M, Grigore FN, Dhawan S, Skorput AGJ, Musial SC, Chen CC, Masopust D, Rosato PC. Ning J, et al. Cancer Immunol Immunother. 2022 Aug;71(8):1863-1875. doi: 10.1007/s00262-021-03125-w. Epub 2022 Jan 10. Cancer Immunol Immunother. 2022. PMID: 35001153 Free PMC article.
Immunovirotherapy for the treatment of glioblastoma.
Cheema TA, Fecci PE, Ning J, Rabkin SD. Cheema TA, et al. Among authors: ning j. Oncoimmunology. 2014 Jan 1;3(1):e27218. doi: 10.4161/onci.27218. Oncoimmunology. 2014. PMID: 24575383 Free PMC article.
iPSC-derived NK cell therapy induces durable responses in glioblastoma and overcomes resistance via a B7-H3-targeted tri-specific killer engager.
Ning JF, Davis ZB, Zeb Q, Hinderlie P, Tuininga K, Wang L, Chaudhary S, Vue Y, Ma J, Zhu S, Zhang Y, Seeman ZJ, Malmberg KJ, Valamehr B, Largaespada DA, Zorko N, Felices M, Cichocki F, Miller JS, Chen CC. Ning JF, et al. Neuro Oncol. 2026 Jul 11:noag154. doi: 10.1093/neuonc/noag154. Online ahead of print. Neuro Oncol. 2026. PMID: 42434963
Correction to: Functional virus‑specific memory T cells survey glioblastoma.
Ning J, Gavil NV, Wu S, Wijeyesinghe S, Weyu E, Ma J, Li M, Grigore FN, Dhawan S, Skorput AGJ, Musial SC, Chen CC, Masopust D, Rosato PC. Ning J, et al. Cancer Immunol Immunother. 2022 Oct;71(10):2577-2579. doi: 10.1007/s00262-022-03168-7. Cancer Immunol Immunother. 2022. PMID: 35179625 Free PMC article. No abstract available.
PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response.
Li J, Kaneda MM, Ma J, Li M, Shepard RM, Patel K, Koga T, Sarver A, Furnari F, Xu B, Dhawan S, Ning J, Zhu H, Wu A, You G, Jiang T, Venteicher AS, Rich JN, Glass CK, Varner JA, Chen CC. Li J, et al. Among authors: ning j. Proc Natl Acad Sci U S A. 2021 Apr 20;118(16):e2009290118. doi: 10.1073/pnas.2009290118. Proc Natl Acad Sci U S A. 2021. PMID: 33846242 Free PMC article.
24 results